dactinomycin has been researched along with Cancer, Second Primary in 29 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 13 (44.83) | 18.2507 |
2000's | 8 (27.59) | 29.6817 |
2010's | 7 (24.14) | 24.3611 |
2020's | 1 (3.45) | 2.80 |
Authors | Studies |
---|---|
Ben-Arush, M; Bisogno, G; Cameron, AL; Casanova, M; Chisholm, JC; Coppadoro, B; Elze, M; Ferman, S; Ferrari, A; Gallego, S; Geoerger, B; Guizani, C; Jenney, M; Kelsey, A; McHugh, K; Merks, JHM; Minard-Colin, V; Orbach, D; Rogers, T; Schoot, RA; van Rijn, RR; Zanetti, I | 1 |
Fernandez-Ledon, S; Forlenza, CJ; Heaton, TE; Kobos, R; LaQuaglia, MP; Ortiz, MV; Ramaswamy, K; Shukla, NN; Steinherz, PG | 1 |
Amann, G; Furtwängler, R; Gräber, S; Graf, N; Kager, L; Leuschner, I; Niggli, F; Schenk, JP; Schmolze, M; von Schweinitz, D | 1 |
Maherus, EM; Rashidi, A | 1 |
Camarata, M; Cooke, R; Dancy, G; Krell, J; Kwan, A; O'Nions, J; Savage, P; Seckl, MJ; Short, D; Swerdlow, A | 1 |
Kim, KJ; Kim, YD; Lee, YH | 1 |
El-Baz, M; Ghali, AM; Ghoneim, MA; Sarhan, MM; Sarhan, OM | 1 |
Khunamornpong, S; Settakorn, J; Siriaunkgul, S; Sukpan, K; Suprasert, P | 1 |
Iwashita, K; Kubo, M; Oyachi, N; Oyama, T; Yamamoto, T | 1 |
Fendel, A; Horger, MS | 1 |
Billups, CA; Davidoff, AM; Krasin, MJ; Kun, LE; Merchant, TE; Neel, MD; Rodriguez-Galindo, C | 1 |
Argani, P; Haase, G; Hamilton, T; Peterson, S; Ritchey, ML; Shamberger, RC | 1 |
Askin, FB; Bhatia, S; Burden, L; Chen, Z; Dickman, PS; Grier, HE; Krailo, MD; Link, MP; Meyers, PA; Miser, JS; Perlman, EJ; Rausen, AR; Robison, LL; Vietti, TJ | 1 |
Affolter, A; Ahmed, M; Marais, R; Nutting, CM; Pritchard-Jones, K; Sharma, AK; Thomas, V; Venkitaraman, R | 1 |
Carpentier, AF; Chantelard, JV; Henin, D; Poisson, M | 1 |
Andrews, R; Begent, RH; Boshoff, C; Holden, L; Newlands, ES; Oliver, RT; Ong, J; Rustin, GJ; Skelton, M | 1 |
Bajorin, DF; Bosl, GJ; Motzer, RJ; Murphy, B; Rodriguez, E | 1 |
Flamant, F; Pein, F; Rialland, X; Saint-Andre, JP | 1 |
Felix, CA; Hosler, MR; Lange, BJ; Masterson, M; Wilson, AE; Winick, NJ | 1 |
Behm, FG; Bowman, LC; Head, DR; Heaton, D; Hurwitz, CA; Pui, CH; Raimondi, SC; Sandoval, C | 1 |
Bagshawe, KD; Foskett, M; Fuller, S; Hiscox, JG; Holden, L; Lutz, JM; Newlands, ES; Rustin, GJ; Short, D | 1 |
Culine, S; Droz, JP; Farhat, F; Philippot, I; Terrier-Lacombe, MJ; Théodore, C | 1 |
Bullimore, JA; Cotterill, SJ; Craft, AW; Pearson, D | 1 |
Donaldson, SS; Gilula, L; Glicksman, A; Laurie, F; Link, MP; Manning, J; Neff, J; Reinus, W; Shuster, JJ; Thompson, E; Torrey, M | 1 |
Ahrens, S; Dunst, J; Harms, D; Jürgens, H; Paulussen, M; Rübe, C; Winkelmann, W; Zoubek, A | 1 |
Davidson, A; Pritchard, J | 1 |
Blair, IA; Felix, CA; Lo Nigro, L; Lovett, BD; Megonigal, MD; Nowell, PC; Osheroff, N; Rappaport, EF; Williams, WR; Zheng, N | 1 |
Ahrens, S; Aulitzky, WE; Dunst, J; Fölsch, UR; Göbel, U; Harms, D; Hense, HW; Henze, G; Jürgens, H; Kremens, B; Lehnert, M; Niemeyer, C; Paulussen, M; Reiter, A; Taeger, D; Voûte, PA; Wagner, A; Zoubek, A | 1 |
Altermatt, HJ; Brunner, KW; Buser, K; Cerny, T; Fravi, R; Ohnacker, H; Oppikofer, C; Ridolfi Lüthy, A | 1 |
2 review(s) available for dactinomycin and Cancer, Second Primary
Article | Year |
---|---|
Bilateral Wilms' tumors: single-center experience with 22 cases and literature review.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Child; Child, Preschool; Combined Modality Therapy; Dactinomycin; Doxorubicin; Egypt; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Infant; Kaplan-Meier Estimate; Kidney Neoplasms; Male; Mesna; Neoadjuvant Therapy; Neoplasms, Multiple Primary; Neoplasms, Second Primary; Nephrectomy; Retrospective Studies; Treatment Outcome; Vincristine; Wilms Tumor | 2010 |
Translocation t(11;19) (q23;p13) in a child with myelomonocytic leukemia following 2 years after chemotherapy for pneumoblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 19; Dactinomycin; Humans; Ifosfamide; Leukemia, Myelomonocytic, Acute; Lung Neoplasms; Male; Neoplasms, Second Primary; Translocation, Genetic; Vincristine | 1993 |
5 trial(s) available for dactinomycin and Cancer, Second Primary
Article | Year |
---|---|
Metastatic Rhabdomyosarcoma: Results of the European
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Humans; Ifosfamide; Neoplasms, Second Primary; Rhabdomyosarcoma; Sarcoma; Vincristine | 2022 |
Therapy-related myelodysplasia and acute myeloid leukemia after Ewing sarcoma and primitive neuroectodermal tumor of bone: A report from the Children's Oncology Group.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Incidence; Infant; Leukemia, Myeloid; Male; Neoplasms, Second Primary; Neural Tube Defects; Neuroectodermal Tumors, Primitive; Proportional Hazards Models; Risk; Sarcoma, Ewing; Vincristine | 2007 |
Long-term results from the first UKCCSG Ewing's Tumour Study (ET-1). United Kingdom Children's Cancer Study Group (UKCCSG) and the Medical Research Council Bone Sarcoma Working Party.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Humans; Infant; L-Lactate Dehydrogenase; Leg; Male; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Proportional Hazards Models; Risk Factors; Sarcoma, Ewing; Survival Analysis; Vincristine | 1997 |
A multidisciplinary study investigating radiotherapy in Ewing's sarcoma: end results of POG #8346. Pediatric Oncology Group.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Female; Humans; Male; Neoplasms, Second Primary; Radiotherapy Dosage; Remission Induction; Sarcoma, Ewing; Treatment Failure; Vincristine | 1998 |
Second malignancies after ewing tumor treatment in 690 patients from a cooperative German/Austrian/Dutch study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Europe; Humans; Ifosfamide; Incidence; Infant; Middle Aged; Neoplasms, Second Primary; Prospective Studies; Radiotherapy Dosage; Sarcoma, Ewing; Vincristine | 2001 |
22 other study(ies) available for dactinomycin and Cancer, Second Primary
Article | Year |
---|---|
Maintenance chemotherapy to reduce the risk of a metachronous Wilms tumor in children with bilateral nephroblastomatosis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Dactinomycin; Female; Follow-Up Studies; Humans; Infant; Kidney Neoplasms; Male; Neoplasms, Second Primary; Prognosis; Retrospective Studies; Survival Rate; Vincristine; Wilms Tumor | 2019 |
Pretreatment for bilateral nephroblastomatosis is an independent risk factor for progressive disease in patients with stage V nephroblastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Transformation, Neoplastic; Child, Preschool; Combined Modality Therapy; Dactinomycin; Disease Progression; Doxorubicin; Female; Humans; Infant; Infant, Newborn; Kidney; Kidney Neoplasms; Male; Neoadjuvant Therapy; Neoplasm Staging; Neoplasms, Multiple Primary; Neoplasms, Second Primary; Nephrectomy; Survival Rate; Tumor Burden; Vincristine; Wilms Tumor | 2014 |
After the treated mole.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Hydatidiform Mole; Immunophenotyping; Leukemia, Myeloid, Acute; Methotrexate; Neoplasms, Second Primary; Pregnancy; Trophoblasts; Vincristine | 2014 |
Effects of single-agent and combination chemotherapy for gestational trophoblastic tumors on risks of second malignancy and early menopause.
Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Child; Cohort Studies; Cyclophosphamide; Dactinomycin; Etoposide; Female; Follow-Up Studies; Gestational Trophoblastic Disease; Humans; Incidence; Kaplan-Meier Estimate; Menopause, Premature; Methotrexate; Middle Aged; Neoplasms, Second Primary; Odds Ratio; Pregnancy; Risk Assessment; Risk Factors; Uterine Neoplasms; Vincristine; Young Adult | 2015 |
Secondary leukemia in a child conceived using in vitro fertilization.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Chemotherapy, Adjuvant; Child, Preschool; Cyclophosphamide; Dactinomycin; Etoposide; Fertilization in Vitro; Humans; Ifosfamide; Leukemia, Myeloid, Acute; Male; Neoplasms, Second Primary; Radiotherapy, Adjuvant; Rhabdomyosarcoma; Vincristine | 2008 |
Ovarian involvement of epithelioid trophoblastic tumor: a case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Etoposide; Female; Humans; Hydatidiform Mole; Immunohistochemistry; Methotrexate; Neoplasms, Second Primary; Ovarian Neoplasms; Pregnancy; Trophoblastic Neoplasms; Uterine Neoplasms | 2011 |
Two different types of infantile renal cell carcinomas associated with tuberous sclerosis.
Topics: Angiofibroma; Angiomyolipoma; Antineoplastic Combined Chemotherapy Protocols; Base Sequence; Carcinoma, Renal Cell; Combined Modality Therapy; Dactinomycin; Diagnostic Errors; Facial Neoplasms; Female; Genetic Predisposition to Disease; Humans; Infant; Intellectual Disability; Kidney Neoplasms; Liver Neoplasms; Male; Molecular Sequence Data; Neoplasms, Second Primary; Nephrectomy; Polycystic Kidney Diseases; Seizures, Febrile; Tuberous Sclerosis; Tuberous Sclerosis Complex 2 Protein; Tumor Suppressor Proteins; Vincristine; Wilms Tumor | 2011 |
[Cover image. Bilateral nephroblastomatosis with secondary Wilms tumor manifestations].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Transformation, Neoplastic; Child, Preschool; Combined Modality Therapy; Dactinomycin; Diagnosis, Differential; Follow-Up Studies; Humans; Infant; Kidney; Kidney Neoplasms; Magnetic Resonance Imaging; Male; Neoplasms, Multiple Primary; Neoplasms, Second Primary; Nephrectomy; Reoperation; Vincristine; Wilms Tumor | 2003 |
Definitive irradiation in multidisciplinary management of localized Ewing sarcoma family of tumors in pediatric patients: outcome and prognostic factors.
Topics: Adolescent; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Ifosfamide; Infant; Male; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Neuroectodermal Tumors, Primitive, Peripheral; Prognosis; Radiotherapy Dosage; Retrospective Studies; Sarcoma, Ewing; Treatment Failure; Vincristine | 2004 |
Fate of bilateral renal lesions missed on preoperative imaging: a report from the National Wilms Tumor Study Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Dactinomycin; Disease-Free Survival; Doxorubicin; Humans; Kidney Neoplasms; Neoplasms, Second Primary; Nephrectomy; Retrospective Studies; Tomography, X-Ray Computed; Vincristine; Wilms Tumor | 2005 |
Childhood papillary thyroid cancer as second malignancy after successful treatment of rhabdomyosarcoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Papillary; Combined Modality Therapy; Dactinomycin; DNA, Neoplasm; Epirubicin; Etoposide; Humans; Ifosfamide; Infant; Iodine Radioisotopes; Male; Neoplasms, Second Primary; Rhabdomyosarcoma, Embryonal; Spinal Neoplasms; Thoracic Vertebrae; Thyroid Neoplasms; Thyroidectomy; Vincristine | 2008 |
Osteosarcoma following radiation treatment for meningioma: report of a case and effective treatment with chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Cisplatin; Dactinomycin; Etoposide; Female; Gonadotropin-Releasing Hormone; Humans; Ifosfamide; Lung Neoplasms; Meningeal Neoplasms; Meningioma; Methotrexate; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Osteosarcoma; Tamoxifen; Tomography, X-Ray Computed; Vincristine | 1994 |
Secondary tumours following etoposide containing therapy for germ cell cancer.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cohort Studies; Cyclophosphamide; Cytarabine; Dactinomycin; Dose-Response Relationship, Drug; Etoposide; Germinoma; Humans; Leukemia, Myeloid; Male; Methotrexate; Middle Aged; Neoplasms, Second Primary; Testicular Neoplasms; Vincristine | 1995 |
Acute nonlymphocytic leukemia in germ cell tumor patients treated with etoposide-containing chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Cyclophosphamide; Dactinomycin; Etoposide; Humans; Leukemia, Myeloid, Acute; Male; Mediastinal Neoplasms; Neoplasms, Germ Cell and Embryonal; Neoplasms, Second Primary; Remission Induction; Salvage Therapy; Testicular Neoplasms; Vinblastine | 1993 |
ALL-1 gene rearrangements in DNA topoisomerase II inhibitor-related leukemia in children.
Topics: Acute Disease; Adolescent; Bone Marrow Transplantation; Child; Child, Preschool; Chromosome Aberrations; Chromosome Deletion; Chromosomes, Human, Pair 11; Combined Modality Therapy; Dactinomycin; DNA-Binding Proteins; Etoposide; Female; Genes; Histone-Lysine N-Methyltransferase; Humans; Infant; Leukemia; Leukemia, Myeloid; Leukemia, Radiation-Induced; Male; Myelodysplastic Syndromes; Myeloid-Lymphoid Leukemia Protein; Neoplasm Proteins; Neoplasms; Neoplasms, Second Primary; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proto-Oncogenes; Radiotherapy; Teniposide; Topoisomerase II Inhibitors; Transcription Factors; Translocation, Genetic; Whole-Body Irradiation | 1995 |
Secondary acute myeloid leukemia in children previously treated with alkylating agents, intercalating topoisomerase II inhibitors, and irradiation.
Topics: Acute Disease; Adolescent; Alkylating Agents; Antineoplastic Agents; Child; Combined Modality Therapy; Dactinomycin; Doxorubicin; Female; Humans; Intercalating Agents; Leukemia, Myeloid; Male; Neoplasms, Second Primary; Podophyllotoxin; Radiotherapy; Topoisomerase II Inhibitors; Translocation, Genetic | 1993 |
Combination but not single-agent methotrexate chemotherapy for gestational trophoblastic tumors increases the incidence of second tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Etoposide; Female; Follow-Up Studies; Humans; Incidence; Methotrexate; Middle Aged; Neoplasms, Second Primary; Pregnancy; Time Factors; Trophoblastic Neoplasms; Uterine Neoplasms | 1996 |
Evaluation of long-term results of a modified VAB-6 chemotherapy regimen in a cohort of good-risk metastatic non seminomatous germ-cell tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Cisplatin; Cohort Studies; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Drug Administration Schedule; Germinoma; Humans; Male; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Prognosis; Testicular Neoplasms; Treatment Outcome; Vinblastine | 1997 |
Second malignancies after treatment for Ewing's sarcoma: a report of the CESS-studies.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Humans; Ifosfamide; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Neoplasms, Second Primary; Radiotherapy Dosage; Sarcoma; Sarcoma, Ewing; Time Factors; Vincristine | 1998 |
Actinomycin D, hepatic toxicity and Wilms' tumour--a mystery explained?
Topics: Antibiotics, Antineoplastic; Child; Dactinomycin; Humans; Kidney Neoplasms; Liver Neoplasms; Neoplasms, Second Primary; Risk Factors; Wilms Tumor | 1998 |
Near-precise interchromosomal recombination and functional DNA topoisomerase II cleavage sites at MLL and AF-4 genomic breakpoints in treatment-related acute lymphoblastic leukemia with t(4;11) translocation.
Topics: Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Catechols; Child; Chromosome Breakage; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 4; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; DNA Topoisomerases, Type II; DNA-Binding Proteins; DNA, Neoplasm; Etoposide; Female; Histone-Lysine N-Methyltransferase; Humans; Ifosfamide; Isoenzymes; Models, Genetic; Molecular Sequence Data; Myeloid-Lymphoid Leukemia Protein; Neoplasm Proteins; Neoplasms, Second Primary; Nuclear Proteins; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proto-Oncogenes; Radiotherapy, Adjuvant; Recombination, Genetic; Rhabdomyosarcoma, Alveolar; Soft Tissue Neoplasms; Transcription Factors; Transcriptional Elongation Factors; Translocation, Genetic; Vincristine | 2001 |
[Leiomyosarcoma of the breast 16 years following successful treatment of a rhabdomyosarcoma of the orbit in childhood].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Child; Cyclophosphamide; Dactinomycin; Female; Humans; Leiomyosarcoma; Neoplasms, Second Primary; Rhabdomyosarcoma; Vincristine | 1992 |